Hidden gout- Ultrasound findings in patients with musculo-skeletal problems and hyperuricemia
نویسندگان
چکیده
منابع مشابه
Hidden gout- Ultrasound findings in patients with musculo-skeletal problems and hyperuricemia
The goal of this study was to investigate the frequency of gout-specific ultrasonography findings in a cohort of hyperuricemic patients with various musculo-skeletal complaints. A blinded examiner regarding the patients' clinical and laboratory assessment performed standardized ultrasound examinations of 12 joints in 74 individuals with diverse musculo-skeletal complaints. Gout-specific changes...
متن کاملMusculo-skeletal ultrasound in rheumatology practice.
In rheumatology ultrasound is a relatively new but rapidly developing field, and now forms an important part of curriculum of rheumatology training programs in European countries. Ultrasound is now an accepted procedure to differentiate between arthralgia and arthritis, to look for erosions in early arthritis which is otherwise not visible on plain radiographs, to scan tendons in enthesopathies...
متن کاملFebuxostat compared with allopurinol in patients with hyperuricemia and gout.
BACKGROUND Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase, is a potential alternative to allopurinol for patients with hyperuricemia and gout. METHODS We randomly assigned 762 patients with gout and with serum urate concentrations of at least 8.0 mg per deciliter (480 micromol per liter) to receive either febuxostat (80 mg or 120 mg) or allopurinol (300 mg) once daily f...
متن کاملIntroduction: hyperuricemia and gout.
The pathophysiology of gout is well understood, and effective treatments for acute gout and hyperuricemia leading to gout are widely available. Nonetheless, many patients suffer from severe tophaceous gouty arthritis, adverse effects of medications for gout, and inadequate treatment of hyperuricemia. The incidence of gout is rising in both men and women. The diagnosis and treatment of gout are ...
متن کاملFebuxostat for the treatment of hyperuricemia in patients with gout
of disease process & therapeutic targets Hyperuricemia, as defined by a serum urate ≥6.8 mg/dl, is necessary but not sufficient to produce the clinical manifestations of gouty arthritis (gout) [1]. Hyperuricemia develops whenever there is a relative imbalance of production and excretion of urate. There are several other risk factors associated with the development of gout, mostly related to the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: SpringerPlus
سال: 2014
ISSN: 2193-1801
DOI: 10.1186/2193-1801-3-592